Literature DB >> 763155

Glucose metabolism in man: responses to intravenous glucose infusion.

R R Wolfe, J R Allsop, J F Burke.   

Abstract

We have determined the effect of unlabeled glucose infusions, with and without added insulin, on glucose metabolism in normal male volunteers by means of the simultaneous primed-constant infusion of 6-3H and U-13C-glucose. Glucose kinetics were measured after 90 min of infusion. When steady state had been reached, endogenous glucose production (2.53 +/- .058 mg/kg . min, X +/- SEM) was suppressed at all rates of exogenous glucose tested (1, 2, and 4 mg/kg . min). The absolute degree of suppression was most marked (75%) at the highest rate of infusion, but the greatest degree of suppression, relative to infusion rate, was at the lowest infusion rate. The control of plasma glucose concentration during the glucose infusion was achieved primarily through regulation of endogenous Ra. The rate of uptake of glucose only increased during the 4 mg/kg . min infusion, even though there were significant elevations in the plasma glucose and insulin concentrations during the 2 mg/kg . min infusion as well. The glucose clearance rate increased only when sufficient insulin was infused with the 4 mg/kg . min glucose infusion to control the hyperglycemia that developed if no insulin was administered. Approximately 43% of the infused glucose was directly oxidized when the infusion rate was 1 or 2 mg/kg . min. That value fell to 32% when the infusion rate was increased to 4 mg/kg . min, regardless of whether insulin was infused or not.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 763155     DOI: 10.1016/0026-0495(79)90066-0

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  55 in total

1.  A fuzzy model of glucose regulation.

Authors:  Em Ward; Terry Martin
Journal:  J Med Syst       Date:  2006-06       Impact factor: 4.460

2.  Glucose, fatty acid, and urea kinetics in patients with severe pancreatitis. The response to substrate infusion and total parenteral nutrition.

Authors:  J H Shaw; R R Wolfe
Journal:  Ann Surg       Date:  1986-12       Impact factor: 12.969

3.  Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man.

Authors:  A Aarsland; D Chinkes; R R Wolfe
Journal:  J Clin Invest       Date:  1996-11-01       Impact factor: 14.808

Review 4.  Stable isotope-based flux studies in nonalcoholic fatty liver disease.

Authors:  Arthur McCullough; Stephen Previs; Takhar Kasumov
Journal:  Pharmacol Ther       Date:  2017-07-16       Impact factor: 12.310

5.  Role of changes in insulin and glucagon in glucose homeostasis in exercise.

Authors:  R R Wolfe; E R Nadel; J H Shaw; L A Stephenson; M H Wolfe
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

6.  Glucose requirements following burn injury. Parameters of optimal glucose infusion and possible hepatic and respiratory abnormalities following excessive glucose intake.

Authors:  J F Burke; R R Wolfe; C J Mullany; D E Mathews; D M Bier
Journal:  Ann Surg       Date:  1979-09       Impact factor: 12.969

7.  Differential effects of insulin on splanchnic and peripheral glucose disposal after an intravenous glucose load in man.

Authors:  L Saccà; M Cicala; B Trimarco; B Ungaro; C Vigorito
Journal:  J Clin Invest       Date:  1982-07       Impact factor: 14.808

8.  The effect of tumor bulk on the metabolic response to cancer.

Authors:  J B Koea; J H Shaw
Journal:  Ann Surg       Date:  1992-03       Impact factor: 12.969

9.  The development of hyperglycaemia in patients with insulin-resistant generalized lipoatrophic syndromes.

Authors:  J J Robert; B Rakotoambinina; I Cochet; V Foussier; J Magre; D Darmaun; D Chevenne; J Capeau
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

Review 10.  Hepatology - Guidelines on Parenteral Nutrition, Chapter 16.

Authors:  M Plauth; T Schuetz
Journal:  Ger Med Sci       Date:  2009-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.